Notice of Transition Relief Regarding the Application of Section 223 to Certain Health Plans Providing Benefits for Male Sterilization or Male Contraceptives
FederalIRS notices
Ask Donna
How this section applies to your facts.
Internal Revenue Bulletin › IRB 2018 › Notice › Notice 2018-12
Text
1
Notice of Transition Relief Regarding the Application of Section 223 to Certain Health Plans
Providing Benefits for Male Sterilization or Male Contraceptives
Notice 2018-12
PURPOSE
This notice clarifies that a health plan providing benefits for male sterilization or male
contraceptives without a deductible, or with a deductible below the minimum deductible for a
high deductible health plan (HDHP) under section 223(c)(2)(A) of the Internal Revenue Code
(Code), is not an HDHP under current guidance interpreting the requirements of section
223(c)(2) of the Code. This notice further provides transition relief for periods before 2020
during which coverage has been provided for male sterilization or male contraceptives without a
deductible, or with a deductible below the minimum deductible for an HDHP.
BACKGROUND
Section 223 of the Code permits eligible individuals to deduct contributions to Health
Savings Accounts (HSAs).1 Among the requirements for an individual to qualify as an eligible
individual under section 223(c)(1) is that the individual be covered under an HDHP and have no
disqualifying health coverage. As defined in section 223(c)(2), an HDHP is a health plan that
satisfies certain requirements, including requirements with respect to minimum deductibles and
maximum out-of-pocket expenses.
Generally, under section 223(c)(2)(A), an HDHP may not provide benefits for any year
until the minimum deductible for that year is satisfied. However, section 223(c)(2)(C) provides
that “[a] plan shall not fail to be treated as a high deductible health plan by reason of failing to
1 Tax-favored contributions may also be made on behalf of eligible individuals by their employers. See
Q&A 19 of Notice 2004-2 (2004-2 I.R.B. 269)
ar
until the minimum deductible for that year is satisfied. However, section 223(c)(2)(C) provides
that “[a] plan shall not fail to be treated as a high deductible health plan by reason of failing to
1 Tax-favored contributions may also be made on behalf of eligible individuals by their employers. See
Q&A 19 of Notice 2004-2 (2004-2 I.R.B. 269).
2
have a deductible for preventive care (within the meaning of section 1871 of the Social Security
Act, except as otherwise provided by the Secretary).”2 Therefore, an HDHP may provide
preventive care benefits as defined for purposes of section 223 without a deductible, or with a
deductible below the minimum annual deductible otherwise required by section 223(c)(2)(A) of
the Code. To be a preventive care benefit as defined for purposes of section 223, the benefit
must either be described as preventive care for purposes of the SSA or be determined to be
preventive care in guidance issued by the Department of the Treasury (Treasury Department)
and the Internal Revenue Service (IRS).
Notice 2004-23 (2004-15 I.R.B. 725) and Q&As 26 and 27 of Notice 2004-50 (2004-33
I.R.B. 196) provide guidance issued by the Treasury Department and the IRS regarding
preventive care benefits that an HDHP may provide without satisfying the minimum deductible
requirement of section 223(c)(2)(A). Notice 2004-23 clarifies that preventive care generally
does not include any service or benefit intended to treat an existing illness, injury, or condition.
Notice 2004-23 also explains that state law requirements do not determine whether
health care constitutes preventive care under section 223(c)(2)(C). State insurance laws often
require health insurance policies and similar arrangements subject to state regulation to provide
certain health care benefits without regard to a deductible or on terms no less favorable than
other care provided by the health insurance policy or arrangement
law requirements do not determine whether
health care constitutes preventive care under section 223(c)(2)(C). State insurance laws often
require health insurance policies and similar arrangements subject to state regulation to provide
certain health care benefits without regard to a deductible or on terms no less favorable than
other care provided by the health insurance policy or arrangement. However, the determination
whether a health care benefit that is required by state law to be provided by an HDHP without
regard to a deductible is “preventive” for purposes of the exception for preventive care under
section 223(c)(2)(C) is based on the standards set forth in guidance issued by the Treasury
Department and the IRS, rather than on how that care is characterized by state law.
Notice 2004-23 further indicates that the Treasury Department and the IRS are
considering the appropriate standard for determining preventive care under section 223(c)(2)(C)
2 Section 1871 of the Social Security Act (SSA) does not address preventive care. Rather, section 1861
of the SSA describes the scope of preventive services for purposes of Medicare.
3
and, in particular, whether any benefit or service should be added to the list of preventive care
benefits and services set forth in Notice 2004-23 or other guidance.
Notice 2004-50, Q&A 27, provides that drugs or medications are preventive care when
taken by a person who has developed risk factors for a disease that has not manifested itself or
become clinically apparent, or to prevent the reoccurrence of a disease from which a person
has recovered.
Section 1001 of the Patient Protection and Affordable Care Act, Pub. L. No. 111-148,
124 Stat
r guidance.
Notice 2004-50, Q&A 27, provides that drugs or medications are preventive care when
taken by a person who has developed risk factors for a disease that has not manifested itself or
become clinically apparent, or to prevent the reoccurrence of a disease from which a person
has recovered.
Section 1001 of the Patient Protection and Affordable Care Act, Pub. L. No. 111-148,
124 Stat. 119 (2010) (Affordable Care Act), added section 2713 to the Public Health Service
Act (PHS Act) requiring non-grandfathered group health plans and health insurance issuers
offering group and individual health insurance coverage to provide benefits for certain
preventive health services without imposing cost-sharing requirements.3 The Affordable Care
Act also added section 715(a)(1) to the Employee Retirement Income Security Act of 1974
(ERISA) and section 9815(a)(1) to the Code to incorporate the provisions of part A of title XXVII
of the PHS Act, including section 2713 of the PHS Act, into ERISA and the Code. Guidance
under section 2713 of the PHS Act is published jointly by the Treasury Department and the
Departments of Labor and Health and Human Services.
Under section 2713(a)(1) of the PHS Act, evidence-based items or services constitute
preventive health services if they have in effect a rating of A or B in the current
recommendations of the United States Preventive Services Task Force (USPSTF) with respect
to the individual involved. Also, preventive health services under section 2713(a)(4) of the PHS
Act include, “with respect to women, such additional preventive care and screenings not
described in paragraph (1) [concerning the USPSTF A or B rated recommendations] as
provided for in comprehensive guidelines supported by the Health Resources and Services
Administration” (HRSA)
F) with respect
to the individual involved. Also, preventive health services under section 2713(a)(4) of the PHS
Act include, “with respect to women, such additional preventive care and screenings not
described in paragraph (1) [concerning the USPSTF A or B rated recommendations] as
provided for in comprehensive guidelines supported by the Health Resources and Services
Administration” (HRSA). HRSA guidelines generally provide for coverage of all Food and Drug
Administration approved contraceptive methods, sterilization procedures, and patient education
3 42 U.S.C. 300gg-13.
4
and counseling for all women with reproductive capacity. The guidelines, however, do not
provide for coverage of benefits or services relating to a man’s reproductive capacity, such as
vasectomies and condoms. (78 FR 8456 (Feb. 6, 2013) at 8458 n. 3.)
Notice 2013-57 (2013-40 I.R.B. 293) provides that any item that is a preventive service
under section 2713 of the PHS Act will also be treated as preventive care under section
223(c)(2)(C) of the Code.
The Treasury Department and the IRS are aware that several states have recently
adopted laws that require certain health insurance policies and arrangements to provide
benefits for male sterilization or male contraceptives without cost sharing.4 Some individuals in
those states are participants or beneficiaries in insured health plans or other arrangements
subject to the state’s insurance laws. Certain stakeholders have asked the Treasury
Department and the IRS whether benefits for male sterilization or male contraceptives constitute
preventive care for purposes of section 223(c)(2)(C).
ANALYSIS
Under section 223(c)(2)(C), “preventive care” means (1) preventive care within the
meaning of section 1871 of the SSA, and (2) preventive care as otherwise provided for by the
Treasury Department and the IRS
s have asked the Treasury
Department and the IRS whether benefits for male sterilization or male contraceptives constitute
preventive care for purposes of section 223(c)(2)(C).
ANALYSIS
Under section 223(c)(2)(C), “preventive care” means (1) preventive care within the
meaning of section 1871 of the SSA, and (2) preventive care as otherwise provided for by the
Treasury Department and the IRS. Benefits for male sterilization or male contraceptives are not
preventive care under the SSA, and no applicable guidance issued by the Treasury Department
and the IRS provides for the treatment of these benefits as preventive care within the meaning
of section 223(c)(2)(C). Accordingly, under current guidance, a health plan that provides
benefits for male sterilization or male contraceptives before satisfying the minimum deductible
for an HDHP under section 223(c)(2)(A) does not constitute an HDHP, regardless of whether
the coverage of such benefits is required by state law. An individual who is not covered by an
4 See, e.g., 215 Ill. Comp. Stat. Ann. 5/356z.4 (West 2017); Md. Code Ann., Insurance § 15-826.2 (West
2017); 2017 Or. Laws Ch. 721, § 2; Vt. Stat. Ann. tit. 8, § 4099c (West 2017).
5
HDHP with respect to a month is not an eligible individual under section 223(c)(1) and,
consequently, may not deduct contributions to an HSA for that month. Similarly, HSA
contributions made by an employer on behalf of the individual are not excludible from income
and wages.
TRANSITION RELIEF
The Treasury Department and the IRS are aware that certain states require benefits for
male sterilization or male contraceptives to be provided without a deductible, and that
individuals have enrolled in health insurance policies and other arrangements that otherwise
would qualify as HDHPs with the understanding that coverage for male sterilization or male
contraceptives without a deductible did not disqualify the policies or arrangements from being
HDHPs
s require benefits for
male sterilization or male contraceptives to be provided without a deductible, and that
individuals have enrolled in health insurance policies and other arrangements that otherwise
would qualify as HDHPs with the understanding that coverage for male sterilization or male
contraceptives without a deductible did not disqualify the policies or arrangements from being
HDHPs. The Treasury Department and IRS also understand that certain states may wish to
change their laws that require benefits for male sterilization or male contraceptives to be
provided without a deductible in response to this notice, but may be unable to do so in 2018
because of limitations on their legislative calendars or for other reasons. Until these states are
able to change their laws, residents of these states may be unable to purchase health insurance
coverage that qualifies as an HDHP and would be unable to deduct contributions to an HSA.
Accordingly, this notice provides transition relief for periods before 2020 (including
periods before the issuance of this notice), to individuals who are, have been, or become
participants in or beneficiaries of a health insurance policy or arrangement that provides benefits
for male sterilization or male contraceptives without a deductible, or with a deductible below the
minimum deductible for an HDHP. For these periods, an individual will not be treated as failing
to qualify as an eligible individual under section 223(c)(1) merely because the individual is
covered by a health insurance policy or arrangement that fails to qualify as an HDHP under
section 223(c)(2) solely because it provides (or provided) coverage for male sterilization or male
contraceptives without a deductible, or with a deductible below the minimum deductible for an
HDHP.
6
REQUEST FOR COMMENTS
The Treasury Department and the IRS continue to consider ways to expand the use and
flexibility of HSAs and HDHPs consistent with the provisions of section 223
P under
section 223(c)(2) solely because it provides (or provided) coverage for male sterilization or male
contraceptives without a deductible, or with a deductible below the minimum deductible for an
HDHP.
6
REQUEST FOR COMMENTS
The Treasury Department and the IRS continue to consider ways to expand the use and
flexibility of HSAs and HDHPs consistent with the provisions of section 223. Accordingly, the
Treasury Department and the IRS request comments on the appropriate standards for
preventive care under section 223(c)(2)(C) (in particular, the appropriate standards for
differentiating between benefits and services that would be considered preventive care and
those that would not be considered preventive care) and other issues related to the provision of
preventive care under an HDHP.
Comments should include a reference to Notice 2018-12. Send submissions to
CC:PA:LPD:PR (Notice 2018-12), Room 5203, Internal Revenue Service, P.O. Box 7604, Ben
Franklin Station, 54 Washington, DC 20044. Submissions may be hand delivered Monday
through Friday between the hours of 8 a.m. and 4 p.m. to CC:PA:LPD:PR (Notice 2018-12),
Courier’s Desk, Internal Revenue Service, 1111 Constitution Avenue, NW, Washington, DC
20224, or sent electronically, via the following e-mail address:
Notice.comments@irscounsel.treas.gov. Please include “Notice 2018-12” in the subject line of
any electronic communication. All material submitted will be available for public inspection and
copying.
DRAFTING INFORMATION
The principal authors of this notice are Karen Levin and Janet Laufer of the Office of
Associate Chief Counsel (Tax Exempt and Governmental Entities), though other Treasury
Department and IRS officials participated in its development. For further information on the
provisions of this notice, contact Karen Levin or Janet Laufer at (202) 317-5500 (not a toll-free
number).
This is a copy of a public record, reproduced as it was published. It is not legal advice, and it may not be the version a court would rely on. Check the official source before you cite it.